Agnes, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 5.039
NA - Nord America 4.725
AS - Asia 1.805
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 12
OC - Oceania 10
Totale 11.628
Nazione #
US - Stati Uniti d'America 4.672
DE - Germania 1.787
SE - Svezia 900
CN - Cina 898
UA - Ucraina 593
IT - Italia 470
SG - Singapore 456
IE - Irlanda 282
FR - Francia 249
GB - Regno Unito 192
FI - Finlandia 182
ID - Indonesia 159
PL - Polonia 157
IN - India 83
RU - Federazione Russa 78
TR - Turchia 77
BE - Belgio 55
CA - Canada 37
HK - Hong Kong 31
IR - Iran 30
KR - Corea 23
JP - Giappone 22
LT - Lituania 14
EU - Europa 13
MX - Messico 13
CH - Svizzera 12
NL - Olanda 12
BR - Brasile 11
CZ - Repubblica Ceca 11
AU - Australia 9
CI - Costa d'Avorio 9
ES - Italia 9
RO - Romania 7
PT - Portogallo 6
VN - Vietnam 6
AT - Austria 5
BG - Bulgaria 4
CL - Cile 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BD - Bangladesh 2
EC - Ecuador 2
KH - Cambogia 2
MD - Moldavia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
BZ - Belize 1
CO - Colombia 1
DO - Repubblica Dominicana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 11.628
Città #
Chandler 979
Ashburn 423
Singapore 353
Jacksonville 338
Dublin 275
San Mateo 269
Ann Arbor 195
Nanjing 184
Jakarta 157
New York 125
Warsaw 122
Boston 118
Wilmington 118
Nürnberg 112
Woodbridge 111
Marseille 103
Beijing 100
Dearborn 91
Lawrence 89
Seattle 86
Bremen 82
Redwood City 81
Rome 80
Cattolica 76
Helsinki 72
Nanchang 69
Houston 68
Izmir 66
Milan 66
Moscow 60
Fairfield 57
Shenyang 57
Hangzhou 54
Princeton 53
Brussels 51
Chicago 51
Munich 51
Lancaster 47
Zhengzhou 45
Hebei 42
University Park 38
Augusta 33
Detroit 33
Mountain View 33
Andover 32
Changsha 28
Tianjin 28
Kunming 26
Norwalk 26
Shanghai 25
Hong Kong 22
London 21
Boardman 20
Guangzhou 19
Jiaxing 19
Los Angeles 19
Jinan 18
Kish 18
Chengdu 17
Toronto 17
Cambridge 16
Leawood 16
Ningbo 15
Pune 15
Frankfurt am Main 14
Fremont 14
Hounslow 14
Kraków 13
San Giovanni Bianco 12
Santa Clara 11
Washington 11
Hefei 10
Abidjan 9
Segrate 9
Seongnam 9
Lanzhou 8
Mcallen 7
Mexico City 7
Ottawa 7
Paris 7
San Diego 7
Seoul 7
Tokyo 7
Ardabil 6
Brno 6
Buffalo 6
Falkenstein 6
Santa Maria 6
São Paulo 6
Ypsilanti 6
Baotou 5
Berlin 5
Changchun 5
Costa Mesa 5
Madrid 5
Monmouth Junction 5
Phoenix 5
Redmond 5
Taizhou 5
Zurich 5
Totale 6.405
Nome #
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 298
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 218
Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center 200
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 184
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 164
Duplex Doppler in the postoperative monitoring of liver transplant recipients 160
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 153
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 145
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 142
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 140
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 139
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 136
Lumbar chemical sympathectomy in end stage of arterial disease: early and late results 131
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 118
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 118
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 117
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 112
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 111
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 111
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 107
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 106
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 105
Model for end-stage liver disease dynamic stratification of survival benefit 104
Prediction of 6-month survival after liver transplantation using Cox regression. 103
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 103
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 102
Psychological risk factors for graft rejection among liver transplant recipients 101
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 100
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 100
Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives 97
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 95
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 94
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 94
Psychological risk factors for graft rejection among liver transplant recipients 94
Fungal infections after liver transplantation: incidence and outcome 94
Liver transplantation in patients with alcoholic liver disease: A retrospective study 93
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 92
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 92
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 92
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 91
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 90
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 90
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 90
Prediction of 6-month survival after liver transplantation using Cox regression 86
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 86
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 85
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 85
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 85
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 84
Anidulafungin--a new therapeutic option for Candida infections in liver transplantation 83
Lamivudine-induced muscle mitochondrial toxicity 83
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 83
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 83
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 82
Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism. 82
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 81
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 81
A Case of Insulinoma Detected by 68Ga-DOTANOC PET/CT and Missed by 18F-Dihydroxyphenylalanine PET/CT 81
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 79
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 79
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 79
Pancreatic function assessment 78
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 77
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 77
Overextended Criteria Donors: Experience of an Italian Transplantation Center 77
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 76
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 75
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 74
Primary difunction after liver trasplantation: donor or recipients fault? 72
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 72
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 72
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 71
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 71
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 70
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 70
Is primary nonfunction still a suitable indication for liver retransplantation? 70
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 70
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 69
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 69
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 69
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 69
Celiac axis compression syndrome in liver transplantation 68
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 68
Pregnancy After Liver Transplant: Neonatal Outcomes and Long-Term Maternal Follow-up 68
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 66
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? 64
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 64
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation 63
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 63
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 62
Should retransplantation still be considered for primary non-function after liver transplantation? 62
Liver Transplantation in Patients with Alcoholic Liver Disease: A Retrospective Study 62
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 61
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 61
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 61
Effect of liver transplantation on intestinal permeability and correlation with infection episodes 61
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation 60
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs. 60
Doppler ultrasonographic evaluation of the early changes in renal resistive index in cirrhotic patients undergoing liver transplantation 59
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 59
Totale 9.353
Categoria #
all - tutte 50.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020862 0 0 0 0 0 125 143 67 121 127 150 129
2020/20211.210 80 125 16 120 177 53 136 19 145 76 239 24
2021/20221.440 84 185 28 104 70 47 10 257 61 83 196 315
2022/20232.789 319 361 258 432 180 360 148 207 305 70 119 30
2023/20241.347 54 426 39 146 58 176 89 43 16 48 127 125
2024/2025814 44 78 235 113 275 69 0 0 0 0 0 0
Totale 11.761